2013-08-27 14:19:50 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to Immunodiagnostic Systems Hldgs PLC (IDH) and produced a report, rating the company's attractiveness to long-term investors.
Ilhavo, Portugal - SADIF Investment Analytics, announces a new summary due diligence report covering Immunodiagnostic Systems Hldgs PLC (IDH). The report uses SADIF's powerful StockMarks™ stock rating system and contains important analysis for any current or potential Immunodiagnostic Systems Hldgs PLC investor.
Report Summary: Immunodiagnostic Systems Hldgs PLC is an average quality company with a neutral outlook. Immunodiagnostic Systems Hldgs PLC has strong business growth and is run by efficient management. The trend in Immunodiagnostic Systems Hldgs PLC fair value exchange rate against its closest rated-competitor, Smith %26 Nephew plc, has been appreciating over the past 2 weeks. When compared to its closest competitor, Immunodiagnostic Systems Hldgs PLC shows similar overvaluation and is equally likely to underperform the market.
The report breaks
down the Total StockMark into its three components - business, management and price, performing an in-depth analysis of Immunodiagnostic Systems Hldgs PLC for long-term investors.
The report has been distributed to Thomson Reuters. It is available in Investext from multiple professional platforms including Thomson Research, Thomson ONE Banker, DIALOG/INTELLISCOPE, Thomson Gale, West Services, Advisen, Alacra-Datadownlink, Factiva, INTERNET SECURITIES and LEXIS/NEXIS or directly from SADIF-Investment Analytics at:
About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering sixteen different markets and over 20,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.